Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-09-04)
Last
 9.94
Change
 ⇑ +0.21   (+2.16%)
Volume
  4,501,676
Open
 9.74
High
 9.97
Low
 9.58
8EMA (Daily)
 10.27
40EMA (Daily)
 10.41
50EMA (Daily)
 10.40
STO (Daily)
 47.952
MACD Hist (Daily)
 -0.001
8EMA (Weekly)
 10.361
40EMA (Weekly)
 10.14
50EMA (Weekly)
 9.93
STO (Weekly)
 31.631
MACD Hist (Weekly)
 -0.131
Stellar Biotechnologies Inc is a biotechnology company. The company is engaged in the aquaculture, research, and development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a variety of diseases. It derives its revenues mostly from Europe. Stellar primarily market and distribute products directly to biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com